Q32 Bio Management to Present at Three Healthcare Investor Conferences
Q32 Bio Inc. says its management will participate in three investor conferences in September 2026, including fireside chats at the Wells Fargo, Cantor, and Morgan Stanley healthcare events. The presentations will be webcast live with replays available for 90 days, alongside progress on its Phase 2 bempikibart program for alopecia areata, an immune-driven condition affecting about 700,000 people in the U.S.